| Dr Eli C Abramson, MD | |
|
5831 Monroe St.#502, Sylvania, OH 43560 | |
| (419) 882-7502 | |
| Not Available |
| Full Name | Dr Eli C Abramson |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Location | 5831 Monroe St.#502, Sylvania, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174744759 | NPI | - | NPPES |
| 35.019480 | Other | OH | STATE LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 35.019480 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Eli C Abramson, MD 5831 Monroe St.#502, Sylvania, OH 43560 Ph: (419) 882-7502 | Dr Eli C Abramson, MD 5831 Monroe St.#502, Sylvania, OH 43560 Ph: (419) 882-7502 |
News Archive
Researchers have shown that living near newly built roads in Ethiopia is associated with higher rates of infant mortality. Proximity to new roads has negative health effects because of toxic waste dumped illegally during the construction phase, according to early research by economists at Queen Mary University of London and Trinity College Dublin.
Seattle Genetics, Inc. today announced that its phase IIb clinical trial of lintuzumab (SGN-33) in older patients with acute myeloid leukemia (AML) did not meet its primary endpoint of extending overall survival. Lintuzumab is a naked monoclonal antibody that targets the CD33 antigen. As a result of the outcome of this trial, the company will discontinue its development program for lintuzumab.
In an April 22, 2011 letter to FDA Commissioner; Dr. Margaret Hamburg, Norma Erickson on behalf of the SaneVax Inc. Board of Directors, criticized the FDA for not following its own guidelines and recommendations in approving Roche's cobas HPV Test for cervical cancer screening and for HPV-16 and HPV-18 genotyping.
Cincinnati burn researchers have created genetically modified skin cells that, when added to cultured skin substitutes, may help fight off potentially lethal infections in patients with severe burns.
There have been significant scientific advances in the field of blood cancers, and leading experts continue to gain a better understanding of how certain diseases progress in order to discover new treatment options and provide patients with the best care.
› Verified 3 days ago
Qunfang Li, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5308 Harroun Rd Ste 55, Sylvania, OH 43560 Phone: 419-824-6599 Fax: 419-882-3870 | |
William L Horvath, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 5308 Harroun Rd, Suite 055, Sylvania, OH 43560 Phone: 419-824-6599 Fax: 419-885-3870 | |
Chang Xia, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5308 Harroun Rd, Suite 055, Sylvania, OH 43560 Phone: 419-824-6599 Fax: 419-882-3870 | |
Mohamad Adam, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5200 Harroun Rd, Sylvania, OH 43560 Phone: 312-504-3267 | |
Charles L Filipiak, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5700 Monroe St Unit 103, Sylvania, OH 43560 Phone: 419-843-7996 Fax: 419-841-7704 | |
Thomas Mcalear, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5700 Monroe St Unit 209, Sylvania, OH 43560 Phone: 419-291-6720 Fax: 419-291-6729 |